Severe Acute Respiratory Syndrome Coronavirus 2 Vaccination for Paediatric Patients With Inflammatory Bowel Diseases

Abstract

In this communication the members of the Porto group (the European Society for Paediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN), Inflammatory Bowel Diseases (IBD) working group) provide the current available evidence regarding vaccination of children and young adolescents with IBD against SARS-CoV-2. Our intent is to help provide meaningful answers to the concerns that parents and adolescents may have.

Keywords

• inflammatory bowel disease
• paediatrics
• severe acute respiratory syndrome coronavirus 2
• vaccination